1. Confidential Resume of<br />LARRY C. McCALL1228 Arch St. #4A Philadelphia, PA 19107<br />215-665-0519 (home) 859.866.0053 (cell)<br /> bewarry@yahoo.com<br />Steering Competitive Advantage<br />FINANCE / MARKETING / INFORMATION MANAGEMENT <br />Proven ability to analyze financial and marketing strategy. Expertise evaluating today’s business conditions to customize and integrate state-of-the-art strategies, systems and decision support models. Skilled at communicating complex information and collaborating with diverse stakeholders. <br /> CFA Candidate, Passed Level 2<br /> MBA, Finance Concentration<br /> Proficiency: Microsoft Excel Access Word PowerPoint Microsoft Project <br /> Hyperion Enterprise Forecast Pro Crystal Ball (Monte Carlo) IMS NGPS SAP/APO<br />CAREER TRACK<br />Sr. Manager, GIBU FORECASTING AND BUSINESS ANALYSIS2006 – Present<br />Manager, CNS BUSINESS ANALYSIS AND FORECASTING2002 – 2006<br />SHIRE PHARMACEUTICALSChesterbrook, PA<br />FINANCIAL/BUSINESS ANALYSIS and FORECASTING<br />Evaluated product NPVs based on assumptions of generic impact leading to strategic decisions<br />Provided product revenue scenarios for products producing revenue of over $600MM to measure short and long-term risks using monte carlo simulation that contributed to business unit decisions <br /> for budget setting, pricing, forecast assumptions and program spending<br />Identified product/program key forecast assumptions drivers and their impact on performance<br />Determined very accurate product revenue forecasts, less than 3% from actual each period <br />STRATEGIC PLANNING<br />Conducted various analyses to support decisions regarding product life cycle management<br />Determined peak share estimates for additional indications using analogues and industry data <br />Developed methods and systems for managing the forecasting process for all products in the CNS, GI and other business units, including business development support and competitive impacts<br />COMMUNICATION<br />Presented product and portfolio performance and business insights regularly to the entire business unit team, including sources of business, trends, and measurement of risks to budget/forecast<br />Delivered portfolio long range plan forecasts to key business unit stakeholders with evidence-based analysis and assumptions development rationale contributing to decisions on future programs<br />Led Sales & Operations Planning process by providing key information to finance, marketing and supply chain colleagues; adjusted units forecasts to minimize costs of excess inventory<br />FINANCIAL / MARKETING CONSULTANT1998 – 2002<br />TIME PROFITS, LLC (Owner)Raleigh, NC<br />FINANCIAL/BUSINESS ANALYSIS and FORECASTING<br />Created financial analysis models to support business development decisions; analyzed pharmaceutical data to enhance and increase the accuracy of the forecasting process for Biovail Pharmaceuticals<br />LARRY C. McCALL 2 of 2<br />STRATEGIC PLANNING<br />Assessed possible licensing opportunities to support the business development function for Bertek Pharmaceuticals<br />Organized, examined and analyzed statistical data to forecast future marketing trends at Bell &<br />Howell Mail Messaging Technologies<br />MARKETING RESEARCH and ANALYSIS<br />Managed $100,000 customer satisfaction and competitive benchmarking study for Bell & Howell;<br />analyzed competitors and future competition trends, performed segmentation analysis on customer revenue; developed integrated product and services pricing model for the sales force; created model to calculate field personnel bonuses; designed models for budgeting, forecasting, and financial data management<br />SR MARKETING RESEARCH ANALYST – New Products and Licensing 1997 – 1998<br />GLAXO WELLCOME (Contractor) RTP / Durham, NC<br />Developed, organized, analyzed and reported primary and secondary research to support potential new product development in BPH, Obesity, Diabetes, Hyperlipidemia, Urinary Incontinence, Male Erectile Dysfunction, Osteoporosis, Poly-cystic Ovarian Syndrome; contributed to decision to continue with product development, eventually becoming Avodart in the BPH market. <br />Supported business development and portfolio management efforts with timely pharmaceutical market analyses and forecasts. <br />MARKETING RESEARCH MANAGER 1994 – 1997<br />MENTIS CORPORATION Durham, NC<br />Managed various research projects and produced reports on banking, data management and technology totaling $400,000+; designed surveys; created forecasts; delivered presentations.<br />SR MUNICIPAL ANALYST/ADVISOR, Southwestern Capital Markets, San Antonio, TX 1991 - 1994 <br />SR MUNICIPAL FINANCING ANALYST, Miller & Schroeder, Solana Beach, CA 1984 – 1990<br />STAFF ACCOUNTANT, KPMG Peat Marwick, San Diego, CA 1983-1984<br /> <br /> PUBLIC FINANCE and ACCOUNTING<br />Structured over $600MM municipal bond financings for local government clients including city and county governments, housing agencies, redevelopment agencies, assessment districts, and school districts<br />Developed and maintained computer systems and financial modeling capabilities to enhance company performance<br />Identified bond refunding opportunities and presented millions of dollars of savings to clients<br />Reviewed bond offering documents with bond attorneys and provided input <br />LEARNING CREDENTIALS<br />CHARTERED FINANCIAL ANALYST CANDIDATE, 2008 - present<br />MASTER OF BUSINESS ADMINISTRATION, 1994<br />University of Texas – San Antonio, Texas Concentration: Finance<br />BACHELOR OF SCIENCE IN BUSINESS ADMINISTRATION<br />University of North Carolina – Chapel Hill – Chapel Hill, North Carolina Concentration: Accounting <br /> <br />